Joanna Bidiuk Zbigniew A Gaciong Piotr Sobieraj
10.5114/aoms/150029
Arch Med Sci
2022 Jun 23;18(4):1095-1099.
empagliflozin glycogen storage disease type ib inflammatory diseases neutrophil dysfunction
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/35982912/
PMC9266796
35982912
The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience
2022